An elegant synthesis of some novel unsymmetrical bis-indol-2,3-diones (4a-d) has been achieved via 1-(6-bromohexyl)-1H-indol-2,3-diones (3a,b). These compounds have been further used for the synthesis of novel bis-spiroindoles (7a-d) via hitherto unknown bis Schiff's bases (6a-d).
Introduction
The discovery and development of heterocyclic systems of pharmaceutical importance has been of enormous interest to synthetic organic chemists owing to their presence in biological systems. Of the various heterocycles known, bis-heterocyclic compounds with a suitable alkyl spacer constitute an important class and have been under study for various types of activities, preferably, antitumor 1 and antimicrobial, 2 based on the DNA binding affinity and enzyme inhibiting actions. These activities, that result in their pharmacological utility, have been reported to be enhanced when different functionalities or substitutions are present on the two heterocyclic moieties in the bis-compound. 3, 4 However, there have been very few reports of this type of unsymmetrical bis compounds containing indole as the basic heterocyclic moiety. Thus, in continuation to our interest on spiro [5] [6] [7] and bis-spiro indoles, 8 we now wish to report the synthesis of some novel unsymmetrical bis-spiroindoles via their corresponding bis-Schiff's bases. These Schiff's bases were prepared from unsymmetrical bis-1H-indol-2,3-diones which in turn have been synthesised using 1-(6-bromohexyl)-1H-indol-2,3-diones as alkylating agents on differently substituted 1H-indol-2,3-diones in presence of sodium hydride as a base.
Results and Discussion
We have synthesised twelve novel bis-indolyl compounds in all besides two new 1-(6-bromohexyl)-1H-indol-2,3-diones.
The reaction of 1H-indol-2,3-dione (1a) with 1,6-dibromohexane (2) in 1:1 ratio in the presence of NaH/DMF at -10°C, has resulted in the formation of mono N-alkylated light orange solid 3a as the major product along with its bis counterpart in minor amounts. Its IR spectrum showed characteristic carbonyl absorption bands at 1738 and 1735 cm -1 . Absence of absorption band in the region 3300-3400 cm -1 (>NH) indicated that N-alkylation has occurred in the indole moiety. This was supported by its 1 H NMR spectrum which displayed two triplets at δ 3.72 and δ 3.40, each integrating for two protons of >NCH 2 and -CH 2 -Br respectively, indicating the presence of 6-bromohexyl group at the nitrogen of the indole moiety. The rest of the methylenes of the hexyl chain appeared as multiplets at δ 1.47, 1.70 and 1.90. The aromatic protons of the indole moiety appeared at δ 6.89 (H-7), δ 7.12 (H-5) and δ 7.56 (H-6 & H-4). In
13
C NMR spectrum, the series of methylenes appeared at δ 27.3, 27.7, 28.8, 29.0, 34.1 (CH 2 -Br) and δ 41.7 (>N-CH 2 ). Also C-2 and C-3 carbonyl carbons showed signals at δ 175.2 and 185.1 respectively. In mass spectra, the molecular ion peak was observed at m/z 310. On the basis of these observations 3a has been identified as 1-(6-bromohexyl)-1H-indol-2,3-dione(Scheme 1). 3a and its 5-fluoro analogue have been used as alkylating agents on differently substituted isatins to obtain various unsymmetrical bis isatins. 
Scheme 1
The reaction of 5-methyl-1H-indol-2,3-dione (1c) with 1-(6-bromohexyl)-1H-indol-2,3-dione (3a) in 1:1 ratio in the presence of NaH/DMF at -10°C resulted in the formation of a yellow solid 4a. Its 1 H NMR spectra displayed a triplet at δ 3.71 integrating for four protons indicating thereby that two indole moieties have been linked together via nitrogen through an alkyl chain. The fact was further supported by the absence of -CH 2 Br signal. The rest of the methylenes of the hexyl spacer appeared as multiplets at δ 1.43 and δ 1.69. A singlet at δ 2.32 integrating for three protons indicated a methyl group in an aromatic ring. The aromatic protons of the indole moieties appeared in the range δ 6.77 and δ 7.58, as expected. Formation of bis product has finally been confirmed on the basis of its mass spectra which showed a molecular ion peak at m/z 390, corresponding to its molecular formula. On the basis of these spectral data 4a has been identified as
Scheme 2
The reaction of 4a with 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (5) in 1:2 ratio, in absolute ethanol, yielded a Schiff's base as an orange coloured solid. Its molecular ion peak, at m/z 760 in FAB-MS, corresponded to the molecular formula C 45 
The cyclocondensation reaction of 6a was carried out with mercaptoacetic acid under refluxing conditions using Dean-Stark apparatus to yield a white solid 7a. Its FAB-MS showed the molecular ion peak at m/z 908, corresponding to the molecular formula C 49 H 48 O 6 N 8 S 2 ,. The IR spectrum showed the presence of characteristic absorptions at 1715(thiazolidinone carbonyl), 1690(lactam carbonyl) and 1678 (pyrazolinyl carbonyl) cm -1 indicating that cycloaddition has occurred. However, the confirmation came from 1 H NMR spectrum as two doublets appeared at On the basis of above spectral studies 7a was assigned structure as -1-[6-(2,3-dioxoindolyl)hexyl]-1H-indol-2,3-dione (4a) . To a stirred solution of NaH in 50 ml of dry DMF, a solution of 5-methyl-1H-indol-2,3-dione (1c) (1g, 3.2mmol) in DMF (5 ml) was added dropwise during 20 min. at -10°C under inert atmosphere of nitrogen. To a resulting deep purple coloured suspension, 1-(6-bromohexyl)-1H-indol-2,3-dione (3a) (510 mg, 3.2 mmol) in DMF was added dropwise during 20 min. at -10°C. The contents were allowed to stir overnight at room temperature. The reaction mixture was then quenched with ice water and a red coloured solid obtained was filtered and purified by column chromatography to obtain 4a. Compounds 4b-d were synthesized using the similar procedure as described for 4a. -1-[6-(3-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)imino-2-oxo-indolyl)hexyl]-3-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl) imino-1H-indol-2-one (6a) . A mixture 5-methyl-1-[6-(2,3-dioxoindolyl)hexyl]-1H-indol-2,3-dione (4a) (780mg, 2mmol) and 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (5) s, 6H, 2xCH 3 ), 3.24 (s, 6H, 2x N-CH 3 Fluoro-1-[6-(3′-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)spiro(3H-indol-3,2′-thiazolidine)-2,4′-dione-1-yl)hexyl]-3′-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)  spiro(3H-indol-3,2′-thiazolidine)-2,4′-dione (7d) 
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